Non-invasive biological imaging requires materials capable of interacting with deeply penetrant forms of energy such as magnetic fields and sound waves. Here, we show that gas vesicles (GVs), a unique class of gas-filled protein nanostructures with differential magnetic susceptibility relative to water, can produce robust contrast in magnetic resonance imaging (MRI) at subnanomolar concentrations, and that this contrast can be inactivated with ultrasound in situ to enable background-free imaging. We demonstrate this capability in vitro, in cells expressing these nanostructures as genetically encoded reporters, and in three model in vivo scenarios. Genetic variants of GVs, differing in their magnetic or mechanical phenotypes, allow multiplexed imaging using parametric MRI and differential acoustic sensitivity. Additionally, clustering-induced changes in MRI contrast enable the design of dynamic molecular sensors. By coupling the complementary physics of MRI and ultrasound, this nanomaterial gives rise to a distinct modality for molecular imaging with unique advantages and capabilities.
T he imaging of cellular and molecular processes inside living animals and patients requires contrast agents compatible with non-invasive imaging modalities such as magnetic resonance imaging (MRI) and ultrasound. Ideally, such contrast agents should be non-toxic, possess the smallest possible dimensions, enable detection at sub-nanomolar concentrations, be expressible by cells through genetic encoding and produce dynamic contrast in response to local molecular signals. Existing contrast agents for MRI, primarily based on heavy metal chelates 1 , superparamagnetic iron oxides 2 , metalloproteins 3, 4 and molecules with chemically exchangeable nuclei [5] [6] [7] , do not fully satisfy these reporter requirements. Here, we show that a unique class of gas-filled, genetically encoded, nanoscale reporters produces robust MRI contrast via differential magnetic susceptibility and can be erased with ultrasound to enable background-free molecular imaging at sub-nanomolar concentrations.
These reporters are based on gas vesicles (GVs), gas-filled protein nanostructures expressed in certain photosynthetic microbes as flotation devices to maintain optimal access to light and nutrients 8, 9 . GVs possess a hollow gas interior, a few hundred nanometres in size, enclosed by a 2 nm protein shell that is permeable to gas but excludes liquid water (Fig. 1a,b ). GVs are physically stable under ambient conditions, and can be collapsed with pressure above genetically determined thresholds of 2-6 atmospheres, leading to the rapid dissolution of their gaseous contents 8 . As a genetically encoded nanomaterial, GVs can be expressed heterologously 10, 11 and have their properties modified through genetic engineering 12 .
Air is a well-known source of contrast in MRI due to its positive magnetic susceptibility compared with diamagnetic water, as seen in image artifacts near gas-filled organs such as the lungs 13 . We reasoned that the air inside GVs would also produce susceptibility-based MRI contrast, which could be observed by T 2 /T 2 *weighted imaging and quantitative susceptibility mapping (QSM). Additionally, because GVs can be collapsed with acoustic pressure 12, 14 , we hypothesized that the MRI contrast produced by GVs could be erased remotely in situ using ultrasound, an orthogonal non-invasive modality. Such acoustically modulated reporters would overcome a major challenge in MRI posed by background contrast from endogenous sources 15 by allowing reporters to be identified specifically based on their acoustic responses. Moreover, this imaging mechanism would be complementary to other recent uses of GVs 14, 16 , creating possibilities for multimodal imaging. In this study, we set out to test these fundamental hypotheses through in vitro and in vivo experiments and computational modelling. In addition, we sought to demonstrate that the unique material properties of GVs could enable multiplexed, functional and genetically encoded molecular imaging.
GVs produce susceptibility-based MRI contrast
To assess the ability of GVs to produce susceptibility-based MRI contrast, we carried out computational modelling and in vitro imaging experiments. The air contents of the GV interior have an expected magnetic susceptibility of + 0.37 ppm, differing significantly from water, which is diamagnetic at − 9.0 ppm ( Fig. 1b) . As a result of this mismatch, individual GVs in aqueous media under a uniform magnetic field are predicted by finite-element modelling to produce nanoscale magnetic field gradients (Fig. 1c) . The proton nuclear spins on water molecules experiencing such gradients are expected to dephase, leading to enhanced T 2 /T 2 * relaxation and a concomitant reduction of local signal intensity in T 2 -and T 2 *weighted images, which can be acquired with widely used spin-echo and gradient-echo MRI pulse sequences 17 . In addition, macroscale volumes containing GVs have a different average susceptibility from surrounding voxels, producing macroscale field gradients ( Fig. 1d) , which should cause a patterned change of spin phase beyond the site of the GVs ( Supplementary Fig. 1 ). These phase changes can be decoded by QSM algorithms to produce contrast maps with additional sensitivity beyond magnitude-only T 2 /T 2 * images 18, 19 .
To test the ability of GV nanostructures to produce these forms of contrast, we purified GVs from the cyanobacterium Anabaena flos-aquae (Ana GVs) and imaged them in agarose phantoms with a 7 T MRI scanner. As predicted, GVs produced robust contrast in T 2 *-and T 2 -weighted images and QSM maps ( Fig. 1e ). Quantification of this MRI contrast revealed T 2 * and T 2 relaxivities of 1.19 ± 0.23 nM −1 s −1 and 0.67 ± 0.11 nM −1 s −1 , respectively, and molar susceptibility of 18.53 ± 0.91 ppb nM −1 (Fig. 1f-h and Supplementary Table 1 ), wherein the nanomolar concentration refers to GV particles. The lowest tested concentration of Ana GVs, at 230 pM, or 73 µ g/mL protein, was readily detectable by QSM (p = 0.0014, unpaired t-test, the first two data points of Fig. 1f , d.f. = 11.86). This protein concentration is within the range of other protein-based MRI reporters such as haem-containing cytochromes, ferritin, aquaporin and chemical exchange saturation transfer polypeptides 20 . At these concentrations, GVs produce negligible T 1 contrast ( Supplementary Fig. 2 ), and have an insignificant effect on proton density due to water exclusion (< 0.1% vol/vol), preserving these contrast modes for use by orthogonal reporters or anatomical imaging. GVs purified from Halobacterium salinarum NRC-1 (Halo GVs) and GVs formed by expressing a GV gene cluster from Bacillus megaterium in Escherichia coli (Mega GVs) produced similar contrast to Ana GVs ( Supplementary Fig. 2 ).
Background-free acoustically modulated imaging
Conventional T 2 and T 2 * contrast agents such as superparamagnetic iron oxide nanoparticles (SPIONs) are widely used in MRI applications such as in vivo cell tracking 21 . However, the specificity with which they can be detected in biological tissues is sometimes confounded by the presence of background contrast from endogenous sources such as blood vessels and tissue interfaces 15 . MR pulse sequences and post-processing methods designed to selectively acquire signals only from SPIONs 22-24 often sacrifice molecular sensitivity, while alternative imaging approaches such as magnetic particle imaging (MPI) and 19 F-MRI lack tissue context [25] [26] [27] [28] . Unlike SPIONs, GVs have a built-in mechanism by which their identity as the source of any given MRI contrast can be ascertained. Namely, the collapse of their gaseous interior under pressure should eliminate GVs' susceptibility mismatch with water ( Fig. 2a ), allowing GV-specific contrast to be revealed by differential imaging. Importantly, such pressure can be applied remotely using ultrasound, rendering the entire imaging paradigm non-invasive and depth unlimited.
We tested this concept by acquiring QSM images of samples containing Mega GVs or buffer before and after acoustic collapse with ultrasound. Subtraction of the pre-collapse image from the image acquired after collapse resulted in background-free contrast specific to the GVs (Fig. 2b ). To demonstrate that this method can distinguish GVs from susceptibility artefacts in T 2 *-weighted imaging, we prepared a phantom containing GVs, regions with lower concentration of agarose and capillary tubes filled with paramagnetic nickel. While GVs are difficult to distinguish from other hyper-and hypo-intense regions in the raw initial image, acoustic collapse and background subtraction enable the specific observation of GVs even at concentrations that were initially difficult to spot by naked eye (Fig. 2c ). This differential contrast is positive because GV collapse leads to a longer T 2 *. To test the acoustically modulated molecular imaging paradigm in vivo, we began by stereotaxically injecting Ana GVs in the striatum of adult C57 mice and imaging them using T 2 *-weighted MRI (Fig. 3a ). We then collapsed the GVs in situ using brief pulses of MRI-guided focused ultrasound 29 and acquired a post-collapse MR image. The resulting differential image, overlaid on a separately acquired anatomical reference, shows specific backgroundfree contrast from the brain region injected with GVs ( Fig. 3b,c) . A contralateral injection of PBS without GVs, subjected to the same MRI and ultrasound pulses, produced no significant contrast. The mean collapse-dependent contrast in the GV-injected region was 23.5 ± 3.8% (mean ± s.e.m., N = 9) compared with 0.4 ± 2.6% for PBS (mean ± s.e.m., N = 6, p = 0.0002, unpaired t-test, d.f. = 12.73). Although we mainly used T 2 *-weighted images for in vivo background-free imaging due to their convenience, QSM-processed susceptibility maps also visualized GVs with a high contrast-to-noise ratio ( Supplementary Fig. 3 ).
Next, we tested the ability of GVs to be imaged in vivo after intravenous (i.v.) administration. GVs injected into the bloodstream are efficiently taken up by the liver 14 , a tissue whose ability to clear particles from circulation serves as an important indicator of hepatic health and tumour diagnosis 30 . Because the liver and surrounding tissues also have high endogenous contrast, hepatic imaging serves as a good test bed for background-subtracted imaging techniques. After administering GVs to mice ( Fig. 3d ), we carried out T 2 *-weighted imaging before, during and after applying focused ultrasound to the liver. A dynamic jump in average signal intensity in the insonated region was readily observed in mice injected with GVs, but not in mice injected with PBS ( Fig. 3e ), producing a clear spot of background-subtracted contrast (Fig. 3f ). The mean collapse-dependent signal change in the GV-injected mice was 5.4 ± 1.4%, compared with 0.1 ± 0.1% for PBS (mean ± s.e.m., N = 8, p = 0.0068, unpaired t-test, d.f. = 7.14) ( Fig. 3g ).
Acoustically modulated imaging of gene expression
After establishing the basic acoustically modulated imaging capabilities of GVs in vitro and in vivo, we tested the ability of these genetically encoded nanostructures to act as reporters of gene expression in living cells. In particular, given the great interest in imaging the mammalian microbiome and bacterial infections 31 , we assessed whether GVs could image inducible gene expression in the model bacterium E. coli. Heterologous expression of a recently developed GV variant comprising a combination of genes from A. flos-aquae and B. megaterium 11 (A2C) was placed under the control of a promoter inducible by isopropyl b-D-1-thiogalactopyranoside (IPTG, Fig. 4a ). Overnight induction resulted in GV expression and robust, acoustically erasable QSM contrast that was absent from cells that were not induced or cells induced to express a control fluorescent protein (Fig. 4b,c ). Notably, the E. coli concentration in the phantom, estimated from OD 600 to be about 14 g/l wet cellular weight 32 , indicates that the GV-containing cells can be detected while comprising less than 1.4% of the imaged volume.
Acoustically modulated multiplexing
Many imaging applications in biomedicine would benefit from the ability to image multiple molecular or cellular signals in the same tissue 33 . Because GVs with different protein compositions collapse at substantially different acoustic pressures 12, 14 , this suggests the possibility of performing acoustically modulated imaging in multiplex by collapsing one population of GVs at a time with ultrasound while acquiring a sequence of MR images ( Fig. 5a ). Voxel-wise intensity changes between successive images should then encode the signal corresponding to each multiplexed GV population.
GVs with different collapse pressures can be obtained by isolating genetically distinct variants or by modifying their shells 12 . Here, we used a variant of Ana GVs (referred to as Ana ΔC ) whose acoustic collapse pressure has been lowered by removing its outer scaffolding protein, GvpC 12 (Fig. 5b ). Since GvpC removal does not alter the morphology of the GV, Ana ΔC produces MRI contrast equivalent to wildtype Ana GVs (Ana WT ). To demonstrate multiplexing, we prepared a phantom with three wells containing Ana ΔC , Ana WT and a 1:1 mixture ( Fig. 5c ). We then acquired three sequential MR images interspersed by ultrasound pulses at Ana ΔC -and Ana WT -collapsing pressures. Changes in the measured magnetic susceptibility of each voxel between the relevant pairs of images revealed the contents of each sample ( Fig. 5c,d) .
Next, to test the multiplexing paradigm and demonstrate the imaging of bacterial gene expression in vivo, we injected Ana ΔC GVs and E. coli cells expressing A2C GVs subcutaneously and acquired sequential MR images interspersed by ultrasound pulses selectively collapsing first Ana ΔC GVs and then A2C GVs at each location ( Fig. 5e ). Difference images revealed significant signal for Ana ΔC GVs only upon low-pressure collapse, since few GVs were left intact to be collapsed at high pressure ( Fig. 5f and Supplementary Fig. 4 ). In contrast, E. coli expressing the more mechanically robust A2C GVs produced a signal change specifically in response to higher pressure. Subtracting the signal change generated by low-pressure ultrasound from the change generated by high-pressure ultrasound enables quantitative assignment of the contrast source ( Fig. 5g,h) . Ana ΔC GVs and A2C-expressing E. coli cells yield positive and negative values, respectively, with + 9.0 ± 2.7% for Ana ΔC and − 8.5 ± 3.3% for A2C GVs (mean ± s.e.m., N = 4, p = 0.0072, unpaired t-test, df = 5.73).
Multiparametric MRI multiplexing
In addition to acoustic multiplexing, we hypothesized that GVs with different shapes and sizes could be distinguished on the basis of their differential effects on T 2 and QSM contrast. GV morphology should alter the nanoscale magnetic field patterns generated by a given quantity of gas, affecting T 2 relaxation 34 . In contrast, the magnetic susceptibility calculated from QSM is expected to depend on the total amount of gas in the sample, independent of its nanoscale arrangement. Each type of GV should therefore have its own parametric fingerprint. We tested this hypothesis using Ana GVs, GVs purified from E. coli expressing a GV gene cluster from Bacillus megaterium (Mega) 10 and GVs purified from Halobacterium salinarum (Halo) ( Fig. 6a ). After measuring the T 2 relaxivity and molar susceptibility values for each molecule (Fig. 6a, Supplementary Fig. 2 Fitted curves represent a sigmoid function obtained by non-linear least-square fitting. c, Representative QSM images taken before ultrasound application (pre), after the low-pressure ultrasound (low) and after high-pressure ultrasound (high) of wells containing Ana WT , Ana ΔC or a 1:1 mixture of the two, as indicated, followed by difference images obtained by pairwise subtraction, colour mapped to distinguish variants collapsing at different pressures, followed by an overlay of the two difference images. The total GV concentrations were 1.37 nM in all three samples and the images were displayed from Mega and Halo GVs to demonstrate multiplexed imaging. Each GV type had a distinct appearance under susceptibility contrast relative to its T 2 relaxivity (Fig. 6b ), and voxel-wise unmixing of susceptibility (Δ χ) and relaxation rate (R 2 ) according to the equation
revealed the quantities of the two GV types in each sample, c α and c β (Fig. 6c ). This multiparametric MRI paradigm 35 has the advantage of being non-destructive compared with acoustic multiplexing, but is statistically less accurate ( Supplementary Fig. 5 ).
Clustering-based molecular sensors
In addition to contrast agents reporting their location, there is considerable interest in the development of dynamic molecular sensors [36] [37] [38] [39] . For example, superparamagnetic nanostructures that cluster in response to molecular signals of interest can increase or decrease T 2 or T 2 * contrast 36, 39, 40 . We hypothesized that GVs would also produce differential MRI contrast based on clustering. In particular the size and magnetic character of GVs places them in the so-called motional averaging regime 34,41-43 of T 2 /T 2 * relaxation, such that their clustering in response to a target analyte should result in an increase in both T 2 * and T 2 relaxivity. We tested this hypothesis using biotin-functionalized Ana GVs mixed with tetrameric streptavidin ( Fig. 6d and Supplementary Fig. 6 ). At appropriate streptavidin concentrations, GVs form micrometre-size clusters (Fig. 6e) , predicted to produce a magnetic field profile with correspondingly large spatial dimensions (Fig. 6f,g) . Upon clustering, T 2 *-and T 2 -weighted images showed dramatic relaxation enhancement compared with controls lacking biotinylation or streptavidin (Fig. 6h) , with R 2 * and R 2 increasing approximately 15-and fivefold, respectively ( Fig. 6i,j) . Remarkably, the QSM image was largely unaltered (Fig. 6k) , as expected given the conservation of total air between the three samples; this allows a change in clustering to be distinguished from an increase in the number of particles, thereby enhancing sensing robustness.
Outlook
Our results establish GVs as protein-based acoustically modulated MRI contrast agents, using the combination of ultrasound and MRI to enable background-free and multiplexed molecular imaging. This imaging modality takes advantage of the material properties of GVs, including both the magnetic susceptibility of their interior as a perturbation of the magnetic field in liquid media and the mechanics of their protein shell allowing collapse at specific acoustic pressures. Acoustically modulated reporters should be particularly useful in imaging scenarios with confounding background contrast 15, [44] [45] [46] .
The distinct size, shape and mechanical properties of genetic variants of GVs provide opportunities for future molecular engineering. For example, GV morphology could be optimized to maximize spin dephasing and T 2 /T 2 * contrast, or to facilitate multiplexing of several GV types on the basis of differential relaxivity. At the same time, engineering GV shells with a greater variety of critical collapse pressures could expand multiplexing ability using acoustic collapse. Between these two modes of multiplexing, non-acoustic multiplexing has the advantage of not requiring an ultrasound system. However, the acoustic approach is more accurate in distinguishing GV concentrations, and is independent of the microscale spatial arrangement of GVs. Genetic or chemical engineering of the GV shell 12,47 also provides a route to designing targeted MRI reporters and sensors, the delivery of which may be facilitated by engineering GVs with smaller sizes 9, 48 . In parallel, engineered genetic circuits incorporating GV reporter genes could be used to image bacteria in vivo.
Several limitations must be addressed in future studies to establish the wider applicability of GVs as acoustically modulated susceptibility contrast agents. First, while the three mouse experiments presented in this study provide proofs of concept for the in vivo implementation of acoustically modulated GV imaging, additional work is needed to demonstrate applications of this technique in biomedically useful scenarios. Such applications could include evaluating hepatic health by imaging the uptake of intravenously injected GVs, labelling specific endothelial or extravascular biomarkers or monitoring bacterial biodistribution. To facilitate such applications, additional experiments are needed to establish the tolerability and immunogenicity of injected GVs. Mice injected with repeated doses of GVs over several days in our study did not exhibit any behavioural abnormality, consistent with previous veterinary assessments 14 . However, more detailed histological and biochemical studies are needed.
In addition, the acoustically modulated imaging protocol can be simplified to replace focused ultrasound with an unfocused source, allowing larger areas of the specimen to experience GV collapse. Unlike ultrasound imaging, which requires sound wave coherence for image reconstruction, acoustically modulated MRI only requires enough ultrasound pressure to reach tissues to collapse GVs, facilitating transmission through bone and providing flexibility in instrument design. Finally, the expression of GVs is currently limited to bacterial hosts. Making mammalian cells capable of producing GVs is an active area of ongoing research.
Together with other recent literature, this study establishes GVs as a tri-modal imaging agent. GVs have recently been explored for ultrasound imaging based on their ability to scatter sound waves 14 , and for hyperpolarized 129 Xe CEST imaging based on the ability of xenon gas to exchange across the GV shell 16 . Compared with pulse-echo ultrasound, acoustically modulated MRI has an advantage in accessing bone-enclosed structures such as the brain. It is also much simpler to implement than hyperpolarized 129 Xe imaging, which requires specialized procedures for gas hyperpolarization and delivery. Nevertheless, the ability of GVs to be visualized with multiple modalities increases their appeal as a molecular imaging nanomaterial.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41563-018-0023-7.
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Methods Expression and purification of GVs. Ana and Halo GVs were purified after expression in their respective host bacteria. Anabaena flos-aquae (CCAP strain 1403/13 F) was cultured in Gorham's media supplemented with BG-11 solution (Sigma) and 10 mM NaHCO 3 at 25 °C, 100 r.p.m. shaking and 1% CO 2 under a 14 h light-10 h dark cycle, and confluency was reached in about 2 weeks. Halobacteria NRC-1 (Carolina Biological Supply) were cultured at 42 °C in ATCC medium 2185 under ambient light and with shaking at 100 r.p.m. Confluency was reached in about 1 week. Both types of culture were transferred to sterile separating funnels. The buoyant cells were allowed to float to the top over a 48 h period. The subnatant was discarded and the floating cells were collected. Anabaena cells were lysed with 500 mM sorbitol and 10% Solulyse solution (Genlantis), and Halobacteria cells were hypotonically lysed with the addition of excess lowsalt TMC buffer (10 mM Tris, pH = 7.5, 2.5 mM MgCl 2 , 2 mM CaCl 2 ). GVs were separated from cell debris by repeated centrifugally assisted floatation followed by resuspension in 1 × PBS (Teknova). The centrifugation speed was carefully controlled to avoid the hydrostatic collapse of GVs. To prepare solution for in vivo experiments, purified GVs were dialysed overnight in 1 × PBS solution. The concentration of GVs was estimated based on the pressure-sensitive optical density at 500 nm (OD 500,PS ) due to the ability of intact GVs to scatter light 8 .
Ana ΔC was prepared by treating Ana GVs with a solution of 6 M urea and 20 mM Tris-HCl (pH = 8.0). Two rounds of centrifugally assisted buoyancy purification were performed to remove GvpC. The solution was then dialysed overnight in 1 × PBS buffer to remove urea.
GVs from Bacillus megaterium (Mega) were heterologously expressed in E. coli Rosetta TM 2(DE3)pLysS (EMD Millipore). The pNL29 region of the Mega GV gene cluster 10 was cloned into the pST39 plasmid for expression under the control of the T7 promoter 16 . The transformed cells were grown at 30 °C in LB media supplemented with 0.2% glucose. 20 µ M isopropyl β -D-1thiogalactopyranoside (IPTG) was added at OD 600 between 0.4 and 0.6 to induce the expression of GVs, and the cells were grown overnight before harvesting by centrifugation. The clear subnatant was removed by a syringe, while both the floating and the pelleted cells were collected. The cells were lysed in 10% Solulyse (Genlantis), 250 µ g ml −1 lysozyme and 10 µ g ml −1 DNaseI. Centrifugally assisted floatation and OD 500 measurement followed the procedure used for Halo and Ana GV. Mega GVs, which are natively clustered after purification from bacteria, were unclustered using the same urea treatment, buoyancy purification and dialysis procedure as described for the preparation of Ana ΔC GVs. GV concentrations were determined using the relationships summarized in Supplementary Table 1 (ref. 47 ).
Reporter gene expression.
For reporter gene experiments, the gene cluster encoding a hybrid GV variant named A2C 11 was cloned into pET28a plasmid (Novagen), and the resulting plasmid was transformed into BL21(A1) cells (Thermo Fisher Scientific). The transformed cells were first grown overnight at 30 °C in LB media supplemented with 1% glucose, and this starter culture was subsequently diluted 1:100 into LB media supplemented with 0.2% glucose. When OD 600 reached between 0.4 and 0.6, 400 µ M IPTG and 0.5% l-arabinose were added to induce expression of GVs. The control green fluorescent protein mNeonGreen 49 was inserted into the same plasmid and followed an identical culturing protocol.
Cell density was measured after collapsing any intracellular GVs to eliminate their contribution to optical scattering ( Supplementary Fig. 7) . A sample of each E. coli specimen at OD 600 ~ 1.0 was loaded onto a flow-through, 1 cm path-length quartz cuvette (Hellma Analytics), which was pressurized by an N 2 cylinder and a digital pressure controller (Alicat Scientific). The pressure was incremented in 20 kPa steps from 0 to 1.2 MPa and OD 600 was recorded using a spectrophotometer (EcoVis, OceanOptics). OD 600 at 1.2 MPa was used to measure cell density. Prior to the preparation of MRI phantoms, the cells were concentrated by centrifugation to the indicated density. For in vivo imaging, the buoyant fraction of cells was concentrated and collected after several rounds of centrifugation at 350 g (4 h).
TEM. GVs at OD 500,PS ~ 0.2 were prepared in a buffer of 10 mM HEPES, 150 mM NaCl (pH 8) and spotted on Formvar/Carbon 200 mesh grids (Ted Pella) that were rendered hydrophilic by glow discharging (Emitek K100X). GV samples were negatively stained using 2% uranyl acetate. Images were acquired using a Tecnai T12 LaB6 120 kV TEM.
In vitro MRI and relaxometry. Purified GVs or E. coli cells were embedded in agarose phantoms. 1% agarose stock solution was prepared in PBS and maintained at 60 °C until use. The size of the phantom was ~18 × 6 × 4 cm 3 (length × width × height). Using a custom 3D-printed caster, the bottom half was first cast with cylindrical wells of size 3 × 5 mm 2 (diameter × depth) separated by 3 mm. The cylindrical geometry perpendicular to B 0 was chosen to ensure a homogeneous field in the sample wells to facilitate susceptibility-based imaging. The gel was allowed to solidify and exposed to air for 1 h for gas equilibration. Two-times concentrated GVs or E. coli cells in PBS were mixed 1:1 with the melted agarose stock solution and immediately loaded into the wells. Subsequently, the top half of the phantom was cast so that all the wells were surrounded by agarose. Care was taken to avoid bubbles.
MRI was performed on a 7 T horizontal bore Bruker BioSpin scanner, using a 7.2 cm diameter volume coil for transmit and receive. T 2 * relaxivity was measured with 3D multi-gradient echo (MGE) experiments with the following parameters: repetition time (T R ) = 500 ms, 32 echoes, echo spacing (T E ) = 9.0 ms, field of view (FOV) = 12 × 6 × 0.8 cm 3 , spatial resolution = 0.25 × 0.25 × 0.25 mm 3 and one average. T 2 relaxometry was carried out with 2D multi-slice multi-echo spin-echo experiments with the following parameters: T R = 2500 ms, 16 echoes, T E = 16.0 ms, FOV = 8 × 6 cm 2 and spatial resolution = 0.25 × 0.25 mm 2 . Slice thickness = 1 mm and 16 averages were used for multiparametric multiplexing experiments, and 0.5 mm and four averages for all other experiments. T 1 relaxometry was performed by 2D rapid acquisition with relaxation enhancement with variable T R (RAREVTR) with the following parameters: effective T E = 9.68 ms, RARE factor = 12, FOV = 8 × 6 cm 2 , spatial resolution = 0.25 × 0.25 mm 2 , slice thickness = 0.5 mm, two averages and eight variable T R times, including 126.4, 738.4, 1461.2, 2344.1, 3478.7, 5068.5, 7746.6 and 20,000.0 ms.
For data analysis, a circular region of interest (ROI) was drawn for each well using Fiji 50 . The average intensity of the ROI was imported into MATLAB for exponential fitting to derive the T 2 *, T 2 and T 1 values. Voxel-wise T 2 * and T 2 maps were generated by the ImageJ plugin MRI Processor, using simplex fitting. For T 2 * relaxometry, the ROI excluded the rim of the wells. Multiparametric multiplexing of GVs was achieved by solving the matrix equation where the concentrations of the two GV species, c α and c β , were the two unknowns. r 2,α and r 2,β were the r 2 relativities and Δ χ m,α and Δ χ m,β were the molecular susceptibility of the GVs, and R 2 exp and χ Δ exp were the experimentally measured relaxation rate and susceptibility (Supplementary Table 1 ).
QSM.
Magnitude and phase images of 3D MGE or 3D fast low-angle shot (FLASH) experiments were obtained in ParaVision 5.1 (Bruker), and the images from a single echo served as the input to the Susceptibility Mapping and Phase Artifacts Removal Toolbox (SMART) (MRI Institute for Biomedical Research). This software performed phase unwrapping using the 3D-SRNCP algorithm 51 , background field removal by the SHARP algorithm 52 and susceptibility map generation using the SWIM algorithm 53 . The resulting QSM images were analysed in Fiji 50 . Unless specified otherwise, all QSM images were processed from the fifth echo (T E = 45.0 ms) of a 3D MGE experiment.
GV clustering. Purified Ana GVs were biotinylated using a 10 5 molar excess of EZ-Link Sulfo-NHS-LC-biotin (Thermo Scientific) for 4 h in PBS buffer. The excess biotin was removed by two rounds of overnight dialysis in PBS buffer. Biotinylated or control GVs at OD 500,PS = 10 were incubated with streptavidin (Geno Technology) at the ratio specific to each experiment for 30 min at room temperature before loading into MRI phantom. Dynamic light scattering measurements were performed using a Zeta-PALS instrument (Brookhaven Instruments) at a concentration equivalent to OD 500,PS = 0.2 in PBS.
In vitro acoustic collapse. Acoustic GV collapse was carried out outside the MRI scanner for in vitro experiments. Multiplexing experiments were carried out with a single-element immersion transducer (Olympus) with transmit frequency 2.25 MHz, element size 0.75 inch, focal length 1.5 inch, pulse duration 10 μ s, duty cycle 0.1%. A waveform generator (Model WS8352, Tabor Electronics) and a power amplifier (Model 3100LA, Electronics & Innovation) were used to drive the transducer. The input voltages to the transducer were 57 V and 131 V for collapsing Ana ΔC and Ana WT GVs in the agarose phantom, respectively. The output peak positive pressures (PPPs) were estimated by a fibre optic hydrophone (Precision Acoustics) to be 0.74 MPa and 1.41 MPa, respectively. To collapse the intracellular GVs in E. coli, a Verasonics Vantage programmable ultrasound scanning system using the L11-4v 128-element linear array transducer was used with the following parameters: transmit frequency 6.25 MHz, transmit voltage 15 V.
Acoustic collapse curves were measured with ultrasound as described previously 12 . Briefly, Ana ΔC at OD 500 = 1, Ana WT at OD 500 = 1, buoyancy-enriched A2C-expressing E. coli at OD 600 = 1 and clustered Ana ΔC at OD 500 = 0.5 (measured prior to clustering) were prepared in agarose phantoms. A 128-element linear array transducer (L22-14v, Verasonics) was used at f-number 2.0 to collapse GVs, and to determine the intact fraction via backscattered ultrasound signal intensity. A ray line script with 15.625 MHz transmit frequency was used for both collapsing GVs and acquiring ultrasound images. To achieve uniform collapse at each acoustic pressure, a mechanical motor system was used to move the transducer over a 6 mm vertical distance at the speed of 0.2 mm s −1 for six repetitions to cover the depth of the agarose well. In addition to the imaging plane, two additional planes spaced at ± 300 μ m along the azimuth were subjected to acoustic collapse to ensure completeness. Transducer output pressure was calibrated by a fibre optic hydrophone (Precision Acoustics).
In vivo injections, MRI and acoustic collapse. All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of the California Institute of Technology. Animals were randomized between experimental groups; blinding was not necessary. Mice were anaesthetized using 1-2.5% isoflurane in all the injection procedures. For intracranial injection, 2 μ l PBS buffer with or without 3.4 nM Ana WT GVs was injected into the striatum or the thalamus of male C57BL6J mice between 12 and 18 weeks of age (Jackson Laboratory) using a Nanofil blunt-end 35g needle coupled with a motorized pump (World Precision Instruments) at 100 nl min −1 using a stereotaxic frame (Kopf). The coordinates of the two pairs of sites with respect to the bregma were + 1 mm anterior-posterior, ± 2 mm medio-lateral, − 3.25 to − 3.5 mm dorso-ventral and − 2.5 mm anterior-posterior, ± 1.5 mm medio-lateral and − 3.25 mm dorso-ventral. The needles remained in place after injection for 5 min to avoid backflow along the needle tract. The OD 500,PS of the GV solution inside the syringe was measured after injection to confirm GV integrity. For intravenous injection, female Nu/J mice 8-20 weeks of age (Jackson Laboratory) were infused with 200 μ l PBS buffer with or without clustered Ana ΔC (13.7 nM, measured before clustering) using a 29g syringe (BD) at a flow rate of 75 μ l min −1 . The mice were euthanized by cervical dislocation 1 min after the end of infusion to enable imaging of the liver without respiratory motion artefacts. For multiplexing experiments, PBS solution containing clustered Ana ΔC (13.7 nM, measured before clustering) or E. coli cells expressing A2C GVs (OD 600 = 150 measured without collapse) were chilled on ice and mixed 1:1 v/v with Matrigel HC (Corning), then injected subcutaneously into the lower abdomen of female Nu/J mice 8-20 weeks of age using 21g syringes in volumes of approximately 200 µ l before live-animal imaging.
For imaging, live mice were anaesthetized using 1-2% isoflurane and were placed in an acrylic cradle, where respiration and body temperature were continuously monitored using a pressure transducer (Biopac Systems) and fibre optic rectal thermometer (Neoptix). Warm air was circulated to maintain body temperature at 30 °C. For brain imaging, a 72 mm diameter volume coil was used for radiofrequency transmission and a 30 mm diameter surface coil for detection. In situ collapse of GVs was achieved using an MRI-guided focused ultrasound system comprising an eight-channel signal generator, a motorized MRI-compatible transducer positioning system and an annular array transducer operating at 1.5 MHz (Image Guided Therapy). For brain imaging, two ultrasound pulse schemes were used to transcranially collapse Ana GVs, with the following parameters: (1) pulse length (PL) = 10 μ s, duty cycle = 0.01 %, PPP = 5.7 MPa, 10 to 200 shots; (2) PL = 50 ms, duty cycle = 5 %, PPP = 3.0 MPa, 100 to 600 shots. Both schemes were capable of collapsing GVs and were tested for both the GV and the control PBS injection sites. For liver imaging, focused ultrasound pulses were applied at a single lateral position, with five axial spots 1 mm apart from each other (using electronic focusing without movement of the transducer) using the following parameters: PL = 10 μ s, duty cycle = 0.1%, PPP = 2.3 MPa and 100 shots for each spot. For multiplexing experiments, regions of interest sized 3.5 × 5 mm 2 or 5 × 5 mm 2 laterally were insonated at an average lateral density of seven focal spots per mm 2 . Each lateral spot received one or two pulses at each of six different electronically focused axial depths, set apart by 1 mm. The pulse parameters were PL = 1 ms, duty cycle = 5%, and PPP = 1.3 MPa for Ana ΔC and 3.2 MPa for A2C. All PPPs were measured using a fibre optic hydrophone (Precision Acoustics) in degassed water. 18% attenuation was assumed for the mouse skull 54 in brain imaging, and no attenuation was assumed for the other experiments.
Data analysis was performed in Fiji 50 . For brain imaging quantification, an elliptical ROI was manually drawn for the hypointense region containing GVs. Another concentric ROI with twice the radius was drawn, and the intensity of the region between the two ROIs was used to measure the intensity of the background tissue. The intensity of the GV region normalized by the background was used to calculate the percentage contrast change upon ultrasound exposure. For liver imaging, a circular ROI 1 mm in radius was drawn at the focal point of the ultrasound for quantification. To obtain the difference images, 50 frames of the 2D-imaging sequence acquired before and after ultrasound application were averaged, and the post-collapse average was subtracted from the pre-collapse average. For quantification, the average intensity change of the pixels within each ROI was divided by that of the post-collapse image, resulting in the percentage signal intensity change. For the multiplexing experiment, images acquired after ultrasound application (averages of three neighbouring planes reconstructed from 3D imaging) were subtracted from the immediately preceding images, and ROIs were drawn corresponding to the insonated areas. To normalize the signal intensity of pre-and post-collapse images, the average intensity of the pixels in an oval area of 20 × 28 mm 2 (width × length) that encompassed the majority of the mouse body was first subtracted from that in each ROI, before the change of signal intensity within ROIs upon insonation was calculated. To obtain the percentage of the Δ Δ signal intensity, the average intensity change of the pixels within each ROI was divided by that of the post-collapse image, and the resulting percentage of Δ signal intensity of high-pressure insonation was subtracted from that of low-pressure insonation.
Finite-element simulations. The magnetic field simulation was performed in Finite Element Method Magnetics (FEMM) version 4.2 (ref. 55 ). GVs were simulated as an axisymmetric object with its longitudinal axis aligned parallel to the magnetic field. The ratio of the susceptibility between inside and outside (χ in /χ out ) of the GVs was taken to be 1 + 9.395 × 10 −6 , which corresponds to the susceptibility difference between air and water. For the inside of the cylindrical well, GVs were assumed to be homogenously distributed, and the ratio of the susceptibility between inside and outside of the well (χ in /χ out ) was set to be 1 + 3.426 × 10 −8 , which was the volume-weighted average for 0.36% air in water, the amount expected for 1 nM concentration of Ana GVs. Then the cylindrical well in an agarose phantom was simulated as a circle in a 2D planar domain. Similarly, the GV cluster was simulated as a single sphere in the axisymmetric domain occupying a volume equivalent of 200 GVs packed at 20% density and χ in /χ out of 1 + 1.879 × 10 −6 for 20% air. In all cases, the external field was set at 7.0 T to correspond to the experimental conditions. Monte Carlo simulation for multiplexing accuracy. The simulation was performed in MATLAB, with N = 100 points simulated for each condition. For simple acoustic multiplexing ( Supplementary Fig. 5a ), the apparent concentration of each GV type was calculated from simulated data using the simple multiplexing assumptions that all GVs of type α were collapsed by low-pressure ultrasound, while all GVs of type β were collapsed only by high-pressure ultrasound. Under this assumption of complete segregation, the molar concentration of the two types of GV, c α and c β , was calculated as Finally, for multiparametric multiplexing ( Supplementary Fig. 5c ), the molar GV concentrations were calculated according to where r 2,α and r 2,β were r 2 relaxivities of GVs of types α and β , and R 2 exp and χ Δ exp were the simulated experimental measurements of R 2 and susceptibility of the sample, simulated according to where δ χ and δ R 2 were normally distributed random numbers using standard deviations observed in Δ χ and R 2 measurements. In simulating the multiplexing between Halo and Mega GVs, δ χ and δ R 2 represented weighted averages of the standard deviations for Halo and Mega GVs ( Supplementary Fig. 1 Corresponding author(s): Mikhail Shapiro
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